Trigeminal Neuralgia
📧 Sign up to get email alerts when something new happens for Trigeminal Neuralgia.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS withdrawal · 2025-12-31Clinical Trial Update: Comorbid Painful TMD Among Trigeminal Neuralgia
A clinical trial investigating comorbid pain conditions in trigeminal neuralgia has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2023-05-06Clinical Trial Update: 802NP302 Efficacy and Safety Study of BIIB074 in Participants With Trigeminal Neuralgia [Phase 3]
A Phase 3 clinical trial of BIIB074 (802NP302) for trigeminal neuralgia was withdrawn.
-
CLINICAL_TRIALS withdrawal · 2023-05-06Clinical Trial Update: 802NP301 Efficacy and Safety Study of BIIB074 in Participants With Trigeminal Neuralgia [Phase 3]
Phase 3 trial of BIIB074 for trigeminal neuralgia was withdrawn.
-
CLINICAL_TRIALS withdrawal · 2019-11-01Clinical Trial Update: Oxtellar Extended Release (Oxcarbazepine Extended Release) Patients With Trigeminal Neuralgia [Phase 4]
A Phase 4 trial evaluating Oxtellar Extended Release (oxcarbazepine extended release) for trigeminal neuralgia has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2015-05-13Clinical Trial Update: CSF Leak Following Microvascular Decompression: the Benefit of Routine Postoperative Lumbar Tap
A clinical trial evaluating routine postoperative lumbar taps to prevent CSF leaks after microvascular decompression has been withdrawn.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS withdrawal · 2012-04-30Clinical Trial Update: Transcranial Magnetic Stimulation (TMS) Effects on Pain Perception [Phase 2, Phase 3]
A Phase 2/3 clinical trial evaluating transcranial magnetic stimulation for pain perception was withdrawn, with conditions including trigemi…